Xoma Corp Stock Today
| XOMA Stock | USD 22.93 0.17 0.74% |
PerformanceVery Weak
| Odds Of DistressVery High
|
XOMA Corp is trading at 22.93 as of the 26th of February 2025, a 0.74% down since the beginning of the trading day. The stock's open price was 23.1. XOMA Corp has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of April 1989 | Category Healthcare | Classification Health Care |
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Xoma Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 11.78 M outstanding shares of which 159.79 K shares are at this time shorted by private and institutional investors with about 2.62 trading days to cover. More on XOMA Corp
Moving against XOMA Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
XOMA Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Owen Hughes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsXOMA Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand XOMA Corp's financial leverage. It provides some insight into what part of XOMA Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XOMA Corp (XOMA) is traded on NASDAQ Exchange in USA. It is located in 2200 Powell Street, EmeryVille, CA, United States, 94608 and employs 13 people. XOMA Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 272.18 M. XOMA Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 11.78 M outstanding shares of which 159.79 K shares are at this time shorted by private and institutional investors with about 2.62 trading days to cover.
XOMA Corp currently holds about 83.7 M in cash with (18.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.31.
Check XOMA Corp Probability Of Bankruptcy
Ownership AllocationThe market capitalization of XOMA Corp is $272.18 Million. Over half of XOMA Corp's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check XOMA Ownership Details
XOMA Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Highvista Strategies Llc | 2024-12-31 | 114.5 K | |
| Eversept Partners, Llc | 2024-12-31 | 95.4 K | |
| Northern Trust Corp | 2024-12-31 | 91.2 K | |
| Acuitas Investments, Llc | 2024-12-31 | 60.7 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 57.5 K | |
| Cm Management, Llc | 2024-12-31 | 55 K | |
| Rbf Llc | 2024-12-31 | 30.6 K | |
| Bridgeway Capital Management, Llc | 2024-12-31 | 25.5 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 23.1 K | |
| Bvf Inc | 2024-12-31 | 3.6 M | |
| Fmr Inc | 2024-12-31 | 1.1 M |
XOMA Corp Historical Income Statement
XOMA Stock Against Markets
XOMA Corp Corporate Executives
Elected by the shareholders, the XOMA Corp's board of directors comprises two types of representatives: XOMA Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of XOMA. The board's role is to monitor XOMA Corp's management team and ensure that shareholders' interests are well served. XOMA Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, XOMA Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Burns | CFO and VP of Fin. | Profile |
Already Invested in XOMA Corp?
The danger of trading XOMA Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of XOMA Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than XOMA Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile XOMA Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether XOMA Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XOMA Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xoma Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xoma Corp Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XOMA Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade XOMA Stock refer to our How to Trade XOMA Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XOMA Corp. If investors know XOMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XOMA Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.37 | Earnings Share (3.07) | Revenue Per Share | Quarterly Revenue Growth 7.671 | Return On Assets |
The market value of XOMA Corp is measured differently than its book value, which is the value of XOMA that is recorded on the company's balance sheet. Investors also form their own opinion of XOMA Corp's value that differs from its market value or its book value, called intrinsic value, which is XOMA Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XOMA Corp's market value can be influenced by many factors that don't directly affect XOMA Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XOMA Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if XOMA Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XOMA Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.